Joseph Zohar
#171,676
Most Influential Person Across History
Joseph Zohar's AcademicInfluence.com Rankings
Download Badge
Psychology
Why Is Joseph Zohar Influential?
(Suggest an Edit or Addition)Joseph Zohar's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Suicide prevention strategies revisited: 10-year systematic review. (2016) (999)
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision (2002) (726)
- Preventing problematic internet use during the COVID-19 pandemic: Consensus guidance (2020) (482)
- Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology (1987) (398)
- Treatment resistant depression: methodological overview and operational criteria (1999) (395)
- Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. (2007) (373)
- Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls. (1987) (364)
- Treatment non-response in OCD: methodological issues and operational definitions. (2002) (361)
- Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care (2012) (341)
- Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment. (1988) (300)
- Blunted HPA Axis Response to Stress Influences Susceptibility to Posttraumatic Stress Response in Rats (2006) (270)
- High dose hydrocortisone immediately after trauma may alter the trajectory of PTSD: Interplay between clinical and animal studies (2011) (256)
- The relevance of differential response to trauma in an animal model of posttraumatic stress disorder (2003) (255)
- Posttraumatic Stress Disorder: Diagnosis and Epidemiology, Comorbidity and Social Consequences, Biology and Treatment (2001) (255)
- The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. (2004) (252)
- Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. (1988) (249)
- Setting Apart the Affected: The Use of Behavioral Criteria in Animal Models of Post Traumatic Stress Disorder (2004) (232)
- Paroxetine versus Clomipramine in the Treatment of Obsessive–Compulsive Disorder (1996) (229)
- An Animal Model of Posttraumatic Stress Disorder: The Use of Cut‐Off Behavioral Criteria (2004) (224)
- The Neuropeptide Y (NPY)-ergic System is Associated with Behavioral Resilience to Stress Exposure in an Animal Model of Post-Traumatic Stress Disorder (2012) (222)
- Epidemiology of obsessive-compulsive disorder: a world view. (1997) (216)
- Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors (2000) (207)
- Double-Blind Placebo-Controlled Pilot Study of Sertraline in Military Veterans With Posttraumatic Stress Disorder (2002) (197)
- Manifesto for a European research network into Problematic Usage of the Internet (2018) (174)
- Early Post-Stressor Intervention with High-Dose Corticosterone Attenuates Posttraumatic Stress Response in an Animal Model of Posttraumatic Stress Disorder (2008) (168)
- Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial. (2019) (166)
- Long-term down-regulation of BDNF mRNA in rat hippocampal CA1 subregion correlates with PTSD-like behavioural stress response. (2007) (147)
- Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice (2009) (145)
- A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder (1993) (144)
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders (2002) (144)
- Animal models of depression and anxiety: What do they tell us about human condition? (2011) (143)
- Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action. (1989) (134)
- Clinical and electrophysiological outcomes of deep TMS over the medial prefrontal and anterior cingulate cortices in OCD patients (2018) (126)
- Anxiety and cerebral blood flow during behavioral challenge. Dissociation of central from peripheral and subjective measures. (1989) (124)
- Anxiogenic effects of m-CPP in patients with panic disorder: Comparison to caffeine's anxiogenic effects (1991) (123)
- A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature (2015) (122)
- European neuropsychopharmacology: The journal of the European College of Neuropsychopharmacology (2009) (120)
- How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology (2020) (119)
- Refractory obsessive-compulsive disorder: state-of-the-art treatment. (2002) (117)
- Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder (1991) (116)
- European Group for the Study of Resistant Depression (GSRD) — Where have we gone so far: Review of clinical and genetic findings (2012) (114)
- Pharmacological Management of Treatment-Resistant Obsessive-Compulsive Disorder (2011) (113)
- Noradrenaline in mood and anxiety disorders: basic and clinical studies (2003) (109)
- Anisomycin, a Protein Synthesis Inhibitor, Disrupts Traumatic Memory Consolidation and Attenuates Posttraumatic Stress Response in Rats (2006) (105)
- Obsessive-compulsive symptoms in schizophrenia: implications for future psychiatric classifications. (2012) (103)
- Alternation learning in obsessive-compulsive disorder (1996) (103)
- Drug treatment of obsessive-compulsive disorder. (1987) (102)
- Compulsive features in behavioural addictions: the case of pathological gambling. (2012) (102)
- Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial (2000) (100)
- The serotonin–dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression (2004) (98)
- Comorbidity in obsessive-compulsive disorder (OCD): a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS). (2014) (97)
- Prolonged exposure therapy for combat- and terror-related posttraumatic stress disorder: a randomized control comparison with treatment as usual. (2011) (95)
- WCA Recommendations for the Long-Term Treatment of Obsessive-Compulsive Disorder in Adults (2003) (95)
- The Contribution of an Animal Model Toward Uncovering Biological Risk Factors for PTSD (2006) (94)
- Switching Antidepressant Class Does Not Improve Response or Remission in Treatment-Resistant Depression (2011) (94)
- Unsupervised Fuzzy Clustering Analysis Supports Behavioral Cutoff Criteria in an Animal Model of Posttraumatic Stress Disorder (2005) (93)
- Food intake, neuroendocrine and temperature effects of 8-OHDPAT in the rat. (1988) (92)
- Hippocampal Microinfusion of Oxytocin Attenuates the Behavioural Response to Stress by Means of Dynamic Interplay with the Glucocorticoid‐Catecholamine Responses (2010) (91)
- New insights into secondary prevention in post-traumatic stress disorder (2011) (91)
- Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives (1985) (89)
- Healing environment in psychiatric hospital design. (1998) (88)
- Gender-related qualitative differences in baseline and post-stress anxiety responses are not reflected in the incidence of criterion-based PTSD-like behaviour patterns (2009) (87)
- Obsessive—Compulsive Disorder as a 5-HT Subsystem-Related Behavioural Disorder (1989) (87)
- Pre-pubertal stress exposure affects adult behavioral response in association with changes in circulating corticosterone and brain-derived neurotrophic factor (2009) (87)
- Posttraumatic stress disorder, tenderness, and fibromyalgia syndrome: are they different entities? (2006) (84)
- Posttraumatic obsessive–compulsive disorder: A case series (2005) (81)
- Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients (2009) (80)
- Serotonergic Dissection of Obsessive Compulsive Symptoms: A Challenge Study with m-Chlorophenylpiperazine and Sumatriptan (2004) (80)
- A proposal for an updated neuropsychopharmacological nomenclature (2014) (80)
- Olfactory sensitivity in major depressive disorder and obsessive compulsive disorder (1994) (76)
- Behavioural addiction—A rising tide? (2016) (76)
- Long-lasting behavioral effects of juvenile trauma in an animal model of PTSD associated with a failure of the autonomic nervous system to recover (2007) (76)
- Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice (2019) (75)
- Post-traumatic stress behavioural responses in inbred mouse strains: can genetic predisposition explain phenotypic vulnerability? (2008) (75)
- Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial. (2000) (74)
- The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression (2015) (74)
- The Effect of Early Poststressor Intervention with Sertraline on Behavioral Responses in an Animal Model of Post-Traumatic Stress Disorder (2006) (74)
- Early intervention for obsessive compulsive disorder: An expert consensus statement (2019) (73)
- Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study (2018) (73)
- Treatment of severe, drug resistant obsessive compulsive disorder with the 5HT1D agonist sumatriptan (1998) (72)
- Cape Town consensus on posttraumatic stress disorder. (2009) (72)
- Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III Sample. (2017) (72)
- Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder (2011) (71)
- Cross-cutting issues and future directions for the OCD spectrum (2009) (70)
- Natural course of posttraumatic stress disorder: a 20-month prospective study of Turkish earthquake survivors. (2006) (70)
- Obsessive Compulsive Disorder: Serotonin and Beyond (2000) (69)
- Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study. (2016) (68)
- Compulsive exhibitionism successfully treated with fluvoxamine: a controlled case study. (1994) (67)
- Bipolar comorbidity: from diagnostic dilemmas to therapeutic challenge. (2003) (66)
- Factors influencing sexual activity after prostatectomy: a prospective study. (1976) (65)
- A New Prediction Model for Evaluating Treatment-Resistant Depression. (2017) (64)
- Current issues in bipolar disorder: A critical review (2007) (63)
- Neuroimaging communality between schizophrenia and obsessive compulsive disorder: A putative basis for schizo-obsessive disorder? (2003) (63)
- Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study. (2017) (62)
- Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients. (1993) (60)
- Serotonin-1D hypothesis of obsessive-compulsive disorder: an update. (2004) (58)
- Alprazolam treatment immediately after stress exposure interferes with the normal HPA-stress response and increases vulnerability to subsequent stress in an animal model of PTSD (2009) (58)
- The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case–control association study (2010) (57)
- Distinctive hippocampal and amygdalar cytoarchitectural changes underlie specific patterns of behavioral disruption following stress exposure in an animal model of PTSD (2014) (56)
- Post-Exposure Sleep Deprivation Facilitates Correctly Timed Interactions Between Glucocorticoid and Adrenergic Systems, which Attenuate Traumatic Stress Responses (2012) (56)
- Can posttraumatic stress disorder be prevented? (2009) (55)
- Obsessive-Compulsive Disorder: Boundary Issues (2007) (55)
- Serotonin in Obsessions, Compulsions, and the Control of Aggressive Impulses (1990) (53)
- Is There Room for a New Diagnostic Subtype—The Schizo-obsessive Subtype? (1997) (52)
- Early post-stressor intervention with minocycline, a second-generation tetracycline, attenuates post-traumatic stress response in an animal model of PTSD (2015) (52)
- Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders (2020) (51)
- A distinct pattern of intracellular glucocorticoid-related responses is associated with extreme behavioral response to stress in an animal model of post-traumatic stress disorder (2009) (51)
- Translationally relevant modeling of PTSD in rodents (2013) (50)
- The pathogenesis and treatment of obsessive-compulsive disorder. (1996) (50)
- Relationship between childhood sexual abuse and obsessive-compulsive disorder: case control study. (2008) (50)
- The immediate early gene Arc is associated with behavioral resilience to stress exposure in an animal model of posttraumatic stress disorder (2008) (50)
- Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers (2014) (49)
- Evaluating the economic impact of screening and treatment for depression in the workplace (2016) (49)
- Early post-stressor intervention with propranolol is ineffective in preventing posttraumatic stress responses in an animal model for PTSD (2011) (49)
- The Role of the Galaninergic System in Modulating Stress-Related Responses in an Animal Model of Posttraumatic Stress Disorder (2009) (49)
- Childhood, adolescent and adult age at onset and related clinical correlates in obsessive–compulsive disorder: a report from the International College of Obsessive–Compulsive Spectrum Disorders (ICOCS) (2016) (49)
- The influence of age at onset and duration of illness on long-term outcome in patients with obsessive-compulsive disorder: A report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) (2013) (48)
- Treating resistant depression (1987) (46)
- A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression. (2011) (46)
- Citalopram versus desipramine in treatment resistant depression: Effect of continuation or switching strategies. A randomized open study (2011) (46)
- Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study (2008) (45)
- Diurnal Fluctuations in HPA and Neuropeptide Y-ergic Systems Underlie Differences in Vulnerability to Traumatic Stress Responses at Different Zeitgeber Times (2015) (45)
- Brain reactivity to specific symptom provocation indicates prospective therapeutic outcome in OCD (2003) (45)
- The effects of chronic lithium and ECT on A1 and A2 adenosine receptor systems in rat brain (1984) (44)
- Motivation to serve in the military influences vulnerability to future posttraumatic stress disorder (2002) (44)
- Temperament and character profiles in bipolar I, bipolar II and major depressive disorder: Impact over illness course, comorbidity pattern and psychopathological features of depression. (2015) (44)
- Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers – A pharmacoepidemiological cross-sectional multicenter study (2016) (43)
- Brief post-stressor treatment with pregabalin in an animal model for PTSD: Short-term anxiolytic effects without long-term anxiogenic effect (2008) (42)
- Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD) (2018) (42)
- A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group. (1993) (42)
- High prevalence of obsessive–compulsive disorder among posttraumatic stress disorder patients (2011) (42)
- The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder — A European Multicenter Study (2012) (42)
- The long-term abnormalities in circadian expression of Period 1 and Period 2 genes in response to stress is normalized by agomelatine administered immediately after exposure (2012) (41)
- 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder (2010) (41)
- Evidence-based national suicide prevention taskforce in Europe: A consensus position paper (2017) (40)
- Immediate ketamine treatment does not prevent posttraumatic stress responses in an animal model for PTSD (2014) (38)
- Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD) (2018) (38)
- WCA Recommendations for the Long-Term Treatment of Posttraumatic Stress Disorder (2003) (37)
- The Characteristic Long-Term Upregulation of Hippocampal NF-κB Complex in PTSD-Like Behavioral Stress Response Is Normalized by High-Dose Corticosterone and Pyrrolidine Dithiocarbamate Administered Immediately after Exposure (2011) (37)
- Manifesto for a European research network into obsessive-compulsive and related disorders (2013) (37)
- Post-traumatic Stress Disorder: Diagnosis, Management and Treatment (2000) (37)
- Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients (2013) (37)
- Emergence of kleptomania during treatment for depression with serotonin selective reuptake inhibitors. (1997) (36)
- Current treatments of obsessive-compulsive disorder (1991) (36)
- Increased olfactory sensitivity in first episode psychosis and the effect of neuroleptic treatment on olfactory sensitivity in schizophrenia (1999) (36)
- The effect of chronic lithium pretreatment on rat brain muscarinic receptor regulation (1982) (36)
- Long‐term imipramine treatment enhances locomotor and food intake suppressant effects of m‐chlorophenylpiperazine in rats (1987) (35)
- Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials (2018) (35)
- Post-traumatic stress disorder: facts and fiction (2008) (35)
- Predator-scent stress, ethanol consumption and the opioid system in an animal model of PTSD (2016) (35)
- Obsessive compulsive symptoms severity among children and adolescents during COVID-19 first wave in Israel (2020) (35)
- Serotonergic drugs in trichotillomania: treatment results in 12 patients. (1996) (34)
- Orbitofrontal cortex dysfunction in obsessive–compulsive disorder? I. Alternation learning in obsessive–compulsive disorder: male–female comparisons (1999) (34)
- Physical activity protects male patients with post-traumatic stress disorder from developing severe fibromyalgia. (2007) (34)
- PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway (2014) (33)
- Prevalence of suicide attempt and clinical characteristics of suicide attempters with obsessive-compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) (2017) (33)
- Beyond refractory obsessions and anxiety states: toward remission. (2004) (33)
- COMT and age at onset in mood disorders: A replication and extension study (2011) (33)
- Risk factors for the development of posttraumatic stress disorder following combat trauma: a semiprospective study. (2009) (32)
- A Consensus Meeting on Effective Research Practice in PTSD (1998) (32)
- A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder (1999) (31)
- Clinical correlates of augmentation/combination treatment strategies in major depressive disorder (2018) (31)
- Prolonged Exposure Therapy for Chronic Combat-Related PTSD: A Case Report of Five Veterans (2007) (31)
- Escitalopram in the prevention of posttraumatic stress disorder: a pilot randomized controlled trial (2015) (30)
- Problematic use of the internet during the COVID-19 pandemic: Good practices and mental health recommendations (2021) (30)
- Pathological Responses to Terrorism (2005) (30)
- Mapping the brain pathways of traumatic memory: Inactivation of protein kinase M zeta in different brain regions disrupts traumatic memory processes and attenuates traumatic stress responses in rats (2010) (30)
- WFS1 gene as a putative biomarker for development of post-traumatic syndrome in an animal model (2009) (30)
- Acute obsessive compulsive disorder (OCD) in veterans with posttraumatic stress disorder (PTSD) (2012) (29)
- Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples (2018) (29)
- Maintaining the clinical relevance of animal models in translational studies of post-traumatic stress disorder. (2014) (29)
- Blunted basal corticosterone pulsatility predicts post-exposure susceptibility to PTSD phenotype in rats (2018) (29)
- Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder (2013) (29)
- Phenomenology of psychotic mood disorders: lifetime and major depressive episode features. (2011) (28)
- Neuronal cell adhesion genes and antidepressant response in three independent samples (2015) (28)
- Preventing sleep on the first resting phase following a traumatic event attenuates anxiety-related responses (2017) (28)
- A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping (2019) (28)
- Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression. (2019) (28)
- How to grade categories of evidence (2008) (28)
- Bipolar II disorder as a risk factor for postpartum depression. (2016) (28)
- Beyond the HPA-axis: The role of the gonadal steroid hormone receptors in modulating stress-related responses in an animal model of PTSD (2015) (27)
- Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder (2013) (27)
- Emergence of depressive symptoms during treatment for panic disorder with specific 5‐hydroxytryptophan reuptake inhibitors (1993) (27)
- The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives (2018) (27)
- Obsessive-Compulsive Disorders: Theory and Management (1987) (27)
- New developments in obsessive‐compulsive disorder research: implications for clinical management (1996) (27)
- Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder (2020) (26)
- Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance (2018) (26)
- An Association Between Stress‐Induced Disruption of the Hypothalamic‐Pituitary‐Adrenal Axis and Disordered Glucose Metabolism in an Animal Model of Post‐Traumatic Stress Disorder (2009) (26)
- Manifesto for a European Anxiety Disorders Research Network (2010) (26)
- Orbitofrontal cortex dysfunction in obsessive-compulsive disorder? II. Olfactory quality discrimination in obsessive-compulsive disorder (1999) (26)
- Addition of estrogen to imipramine in female-resistant depressives. (1985) (26)
- Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression. (2018) (25)
- Temperament and character influence on depression treatment outcome. (2019) (25)
- Exercise Enhances the Behavioral Responses to Acute Stress in an Animal Model of PTSD. (2015) (24)
- Is there sexual dimorphism in obsessive-compulsive disorder? (1999) (24)
- Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression (2012) (23)
- Trichotillomania, Skin Picking, and Other Body-Focused Repetitive Behaviors (2012) (23)
- A new nomenclature for classifying psychotropic drugs. (2017) (23)
- Significance of the orexinergic system in modulating stress-related responses in an animal model of post-traumatic stress disorder (2020) (23)
- OCSDs in the Forthcoming DSM-V (2007) (22)
- Adjunctive treatment with brexpiprazole and escitalopram reduces behavioral stress responses and increase hypothalamic NPY immunoreactivity in a rat model of PTSD-like symptoms (2018) (22)
- Failure to Replicate Influence of GRIK4 and GNB3 Polymorphisms on Treatment Outcome in Major Depression (2012) (22)
- The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment – a European multicentre study (2016) (21)
- Generalized seizures caused by fluoxetine overdose. (1998) (21)
- Cigarette smoking in patients with obsessive compulsive disorder: a report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) (2015) (21)
- Obsessive-compulsive disorder and alcoholism. (1986) (20)
- Animal Models of Posttraumatic Stress Disorder (2008) (20)
- The Premenstrual Syndrome and Fibromyalgia—Similarities and Common Features (2010) (20)
- Microinfusion of a Corticotrophin‐Releasing Hormone Receptor 1 Antisense Oligodeoxynucleotide into the Dorsal Hippocampus Attenuates Stress Responses at Specific Times After Stress Exposure (2012) (20)
- Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression (2019) (20)
- Obsessive-Compulsive Disorder: Current Science and Clinical Practice (2012) (19)
- A New Treatment Algorithm for Posttraumatic Stress Disorder (2005) (19)
- Potentiation of Seizure Length and Clinical Response to Electroconvulsive Therapy by Caffeine Pretreatment: A Case Report. (1985) (18)
- The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk—a European multicentre study on treatment-resistant major depressive disorder (2013) (18)
- The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes – Results from a cross-sectional European multicenter study (2017) (17)
- Compulsivity—A new trans-diagnostic research domain for the Roadmap for Mental Health Research in Europe (ROAMER) and Research Domain Criteria (RDoC) initiatives (2016) (17)
- Clorgyline treatment differentially affects m-chlorophenylpiperazine-induced neuroendocrine changes. (1988) (17)
- Identification of clinical factors associated with resistance to antidepressants in bipolar depression: results from an European Multicentre Study (2010) (17)
- Distinctive cardiac autonomic dysfunction following stress exposure in both sexes in an animal model of PTSD (2016) (17)
- The different faces of Creutzfeldt-Jacob disease CJD in psychiatry. (2014) (17)
- Current Concepts in the Pharmacological Treatment of Obsessive-Compulsive Disorder (1992) (17)
- Social dysfunction in mood disorders and schizophrenia: Clinical modulators in four independent samples (2019) (17)
- Treatment with Ziprasidone for schizophrenia patients with OCD (2014) (16)
- Comorbid hypertension in patients with major depressive disorder – Results from a European multicenter study (2019) (16)
- Neuropeptide S in the basolateral amygdala mediates an adaptive behavioral stress response in a rat model of posttraumatic stress disorder by increasing the expression of BDNF and the neuropeptide YY1 receptor (2018) (16)
- Neuroscience-based Nomenclature (NbN): A call for action (2016) (16)
- Deep Transcranial Magnetic Stimulation Combined With Brief Exposure for Posttraumatic Stress Disorder: A Prospective Multisite Randomized Trial (2021) (16)
- Cyclic GMP in the CSF of patients with schizophrenia before and after neuroleptic treatment (1976) (16)
- Blunting of the HPA-axis underlies the lack of preventive efficacy of early post-stressor single-dose Delta-9-tetrahydrocannabinol (THC) (2014) (16)
- Neuroleptics reduce spinal fluid cyclic AMP in schizophrenic patient. (1976) (15)
- Cyclic nucleotides in mental disorder. (1980) (15)
- Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance (2017) (15)
- Screening for new antidepressants with fast onset and long‐lasting action (2000) (15)
- What to expect from a third step in treatment resistant depression: A prospective open study on escitalopram (2015) (15)
- Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study (2020) (15)
- A pilot study of the “Continuation of Care” model in “revolving-door” patients (2012) (14)
- Dimensions of Delusions in Major Depression: Socio-demographic and Clinical Correlates in an Unipolar-Bipolar Sample (2015) (14)
- Fluvoxamine as effective as clomipramine against symptoms of severe depression: results from a multicentre, double‐blind study (2003) (14)
- The response of lymphocyte beta-adrenergic receptors to chronic propranolol treatment in depressed patients, schizophrenic patients, and normal controls. (1983) (14)
- Evidence for striatal modulation in the presence of fixed cortical injury in obsessive-compulsive disorder (OCD). (1999) (14)
- Variation in the HTR1A and HTR2A genes and social adjustment in depressed patients. (2013) (14)
- Sex‐related effects in major depressive disorder: Results of the European Group for the Study of Resistant Depression (2021) (14)
- Anxiogenic effects of Sumatriptan in panic disorder: A double-blind, placebo-controlled study (2005) (13)
- Chronic lithium treatment increases the phosphorylation of a 64-kDa protein in rat brains (1987) (13)
- Suicidal Ideation Versus Suicidal Obsession: A Case Report (2007) (13)
- Salbutamol treatment of depression. (1982) (13)
- Treatment of Obsessive-Compulsive Syndromes in Schizophrenia (1997) (13)
- Secondary Prevention of Chronic PTSD by Early and Short-Term Administration of Escitalopram: A Prospective Randomized, Placebo-Controlled, Double-Blind Trial. (2017) (13)
- Escitalopram in the treatment of obsessive–compulsive disorder (2008) (12)
- Clinical correlates of CSF cyclic nucleotides in schizophrenia. (1978) (12)
- Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression – Results from a European multicenter study (2018) (12)
- Remission of Tardive Dystonia with ECT. (1991) (12)
- The Impact of Adverse Life Events on Clinical Features and Interaction with Gene Variants in Mood Disorder Patients (2013) (12)
- Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study (2020) (12)
- Standards of care for obsessive–compulsive disorder centres (2016) (11)
- What's in a Name? Moving to Neuroscience-Based Nomenclature in Pediatric Psychopharmacology. (2018) (11)
- Obsessive-compulsive disorder. (2020) (11)
- Current Diagnostic Issues and Epidemiological Insights in PTSD (1998) (11)
- Inverse agonists – What do they mean for psychiatry? (2017) (11)
- Sinus bradycardia due to fluvoxamine overdose (1994) (11)
- Obsessive-compulsive disorder in the elderly: A report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) (2017) (11)
- S-1-2 The relevance of behavioral probes in obsessive-compulsive disorder (1995) (10)
- The Potential Role of 5-HT1D Receptors in the Pathophysiology and Treatment of Obsessive-Compulsive Disorder (1998) (10)
- Sleeplessness (1885) (10)
- COMPARISON OF CRIMINAL ACTIVITY BETWEEN ISRAELI VETERANS WITH AND WITHOUT PTSD (2014) (10)
- Melancholic features in major depression – a European multicenter study (2021) (10)
- Deep Transcranial Magnetic Stimulation (Tms) in Obsessive Compulsive Disorder (Ocd) Patients (2015) (10)
- Protein synthesis inhibition before or after stress exposure results in divergent endocrine and BDNF responses disassociated from behavioral responses (2008) (10)
- The wake-promoting drug modafinil stimulates specific hypothalamic circuits to promote adaptive stress responses in an animal model of PTSD (2016) (10)
- No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression (2011) (10)
- Exercise Maintains Dendritic Complexity in an Animal Model of Posttraumatic Stress Disorder. (2016) (9)
- Serotonergic probes in obsessive compulsive disorder. (1992) (9)
- From self-induced to perceived errors – A generalized over-monitoring activity in obsessive–compulsive disorder (2019) (9)
- Treatment resistance in severe unipolar depression: no association with psychotic or melancholic features. (2013) (9)
- Effects of agomelatine on behaviour, circadian expression of period 1 and period 2 clock genes and neuroplastic markers in the predator scent stress rat model of PTSD (2018) (9)
- High occupational level is associated with poor response to treatment of depression (2016) (9)
- S.26.02 Is 5HT5D involved in obsessive compulsive disorder? (1996) (9)
- The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries (2022) (8)
- Treatment of Resistant Ocd (1996) (8)
- DIAGNOSIS OF POSTTRAUMATIC STRESS DISORDER AFTER SURGERY FOR PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT (2013) (8)
- World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part II: OCD and PTSD (2022) (8)
- The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study (2017) (8)
- A general hospital study of attempted suicide in adolescence: age and method of attempt. (1997) (8)
- UPDATE OF THE SEROTONERGIC HYPOTHESIS OF OBSESSIVE COMPULSIVE DISORDER (1992) (8)
- World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders (2022) (8)
- Association study of CREB1 polymorphisms and suicidality in MDD: results from a European multicenter study on treatment resistant depression (2015) (8)
- Mixed, melancholic, and anxious features in depression: a cross-sectional study of sociodemographic and clinical correlates. (2014) (8)
- “Schizo-Obsessive” Subtype: Obsessions and Delusions (1998) (8)
- Is PTSD-Phenotype Associated with HPA-Axis Sensitivity? Feedback Inhibition and Other Modulating Factors of Glucocorticoid Signaling Dynamics (2021) (8)
- Lifetime bipolar disorder comorbidity and related clinical characteristics in patients with primary obsessive compulsive disorder: a report from the International College of Obsessive–Compulsive Spectrum Disorders (ICOCS) (2019) (8)
- OCD: Towards DSM-V (2007) (8)
- Socio-demographic and clinical characterization of patients with obsessive-compulsive tic-related disorder (OCTD) : An Italian multicenter study (2018) (7)
- Mortality rates between treated post-traumatic stress disorder Israeli male veterans compared to non-diagnosed veterans (2014) (7)
- Lithium does not prevent agonist-induced subsensitivity of human adenylate cyclase. (1982) (7)
- Genetic variants associated with psychotic symptoms across psychiatric disorders (2020) (7)
- A comparison between print vs. internet methods for a clinical trial recruitment—A pan European OCD study (2014) (7)
- Development of a maleic acid-based material to selectively solid-phase extract basic compounds from environmental samples. (2021) (7)
- Is caffeine involved in the pathogenesis of combat-stress reaction? (1996) (7)
- Differential effects of antidepressant treatments on fenfluramine-induced increases in plasma prolactin and corticosterone in rats (1991) (7)
- Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression. (2021) (6)
- PTSD treatment in light of DSM-5 and the “golden hours” concept (2016) (6)
- Obsessive Compulsive Disorder during COVID-19 - two- and six-month follow-ups.OCD during COVID-19. (2021) (6)
- The “Cut-Off Behavioral Criteria” Method: Modeling Clinical Diagnostic Criteria in Animal Studies of PTSD (2011) (6)
- Response to missile attacks on civilian targets in patients with panic disorder. (1999) (6)
- Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts (2021) (6)
- Long-term imipramine treatment potentiates m-chlorophenylpiperazine-induced changes in prolactin but not corticosterone or growth hormone levels in rats (1989) (6)
- Family history of major depression and residual symptoms in responder and non-responder depressed patients. (2014) (6)
- Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression (2020) (6)
- Low comorbid obsessive-compulsive disorder in patients with major depressive disorder - Findings from a European multicenter study. (2018) (6)
- Neuroscience-based nomenclature of psychotropics: Progress report (2022) (6)
- Opinion paper: poor response to treatment of depression in people in high occupational levels (2018) (5)
- Pharmacological Treatment of Obsessive‐Compulsive Disorder: A Review (2001) (5)
- Effect of lysine vasopressin in depressed patients on mood and 24-hour rhythm of growth hormone, cortisol, melatonin and prolactin (1985) (5)
- Salivary and blood levels of neuroleptics during outpatient maintenance treatment. (1986) (5)
- [CAN POST-TRAUMATIC STRESS DISORDER BE PREVENTED WITH GLUCOCORTICOIDS?] (2016) (5)
- The serotonin transporter and the activity regulated cytoskeleton‐associated protein genes in antidepressant response and resistance: 5‐HTTLPR and other variants (2018) (5)
- A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response (2021) (5)
- From Obsessive-Compulsive Spectrum to Obsessive-Compulsive Disorders: The Cape Town Consensus Statement (2007) (5)
- Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: Lack of association with clinical phenotypes (2010) (5)
- Haloperidol blood levels during dosage reduction in chronic schizophrenic patients. (1981) (5)
- patients with mood disorders (2009) (5)
- Long-term lithium treatment in rats attenuates m-chlorophenylpiperazine-induced decreases in food intake but not locomotor activity (2004) (5)
- Coexistence of eosinophilia and agranulocytosis in a clozapine-treated patient (1997) (5)
- Hormonal Responses to Serotonergic Drugs as a Means to Evaluate Brain Serotonergic Function in Humans (1990) (4)
- Serotonergic probes in obsessive-compulsive disorder (1991) (4)
- Physical Comorbidity among Treatment Resistant vs . Treatment Responsive Patients with Major Depressive Disorder (2014) (4)
- Update on the epidemiology, diagnosis, and treatment of posttraumatic stress disorder (2000) (4)
- Discrepancies Between Nomenclature and Indications of Psychotropics (2018) (4)
- P.3.22 Predictive factors of resistance to antidepressant treatment: results from a European multicentre study (2005) (4)
- Social adjustment among treatment responder patients with mood disorders. (2013) (4)
- The Role of Microglia in the (Mal)adaptive Response to Traumatic Experience in an Animal Model of PTSD (2022) (4)
- Lack of benefit from magnesium in lithium toxicity. (1982) (4)
- Pharmacotherapy of Obsessive Compulsive Disorder (1997) (4)
- WCA Recommendations for the Long-Term Treatment of Anxiety Disorders (2003) (4)
- Pindolol augmentation in treatment-resistant panic disorder and obsessive-compulsive disorder (1998) (4)
- Diagnosis and Treatment of Obsessive-Compulsive Disorder (1988) (4)
- Introduction: Exploring the boundaries of obsessive-compulsive disorder and other anxiety disorders (2002) (4)
- Antipsychotics in anxiety disorders: An oxymoron or a reflection of non-adequate nomenclature? (2011) (4)
- Prevalence and correlates of current suicide risk in an international sample of OCD adults: A report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) network and Obsessive Compulsive and Related Disorders Network (OCRN) of the European College of Neuropsychopharmacol (2021) (3)
- MDMA treatment paired with a trauma-cue promotes adaptive stress responses in a translational model of PTSD in rats (2022) (3)
- Intensive outpatient treatment for obsessive-compulsive spectrum disorders. (2008) (3)
- The Cape Town consensus on posttraumatic stress disorder: introduction. (2009) (3)
- Developing models of balanced mental health care : the case of Pakistan (3)
- Obsessive Compulsive Disorder During Coronavirus Disease 2019 (COVID-19): 2- and 6-Month Follow-Ups in a Clinical Trial (2021) (3)
- Neuroleptics, olfactory sensitivity and schizophrenia (1995) (3)
- The role of gender in a large international OCD sample: A Report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) Network. (2022) (3)
- Polygenic risk scores for neuropsychiatric, inflammatory, and cardio‐metabolic traits highlight possible genetic overlap with suicide attempt and treatment‐emergent suicidal ideation (2022) (3)
- Post‐Traumatic Stress Disorder in Animal Models (2009) (3)
- Posttraumatic Stress Disorder: A Hidden Epidemic (2003) (3)
- Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression (2020) (3)
- Differential effect of lithium treatment on fenfluramine-induced decreases in food intake and locomotor activity in rats (1991) (3)
- Neuroimaging Research and Neurocircuitry Models of Obsessive-Compulsive Disorder: Proceedings of the Third IOCDC (1999) (3)
- Addiction, impulsivity and obsessive-compulsive disorder: new formulation revealing ancient wisdom. (2010) (3)
- Treatment duration of obsessive compulsive disorder (1996) (3)
- Is PTSD-Phenotype Associated with HPA-Axis Sensitivity?: The Endocannabinoid System in Modulating Stress Response in Rats (2021) (3)
- Neurobiological and Behavioral Consequences of Terrorism (2006) (3)
- [Brain imaging and its clinical application in psychiatry]. (1997) (3)
- From checking the door to checking the app: assessment and treatment implications for obsessive–compulsive disorder in the digital era (2020) (3)
- The Role of Relationship Status in Major Depressive Disorder - Results of the European Group for the Study of Resistant Depression. (2021) (3)
- Human compulsivity: A perspective from evolutionary medicine (2016) (3)
- O14. Deep TMS of the Medial Prefrontal and Anterior Cingulate Cortices for OCD: A Double-Blinded Multi-Center Study (2018) (2)
- S-21-3 Predictors of response in obsessive-compulsive disorder (1996) (2)
- A prospective clinical cohort-based study of the prevalence of OCD, obsessive compulsive and related disorders, and tics in families of patients with OCD (2022) (2)
- Hormonal stimulation of ovulation, spermiation and spawning in cultured Senegalese sole (Solea senegalensis) broodstock (2008) (2)
- Anxiety Disorders in the Elderly: Treatment Considerations (1998) (2)
- Is multiple cavernoma a developmental defect in schizophrenia? (2004) (2)
- Metabolizing status of CYP2C19 in response and side effects to medications for depression: Results from a naturalistic study (2022) (2)
- Beyond the HPA-axis: the role of the gonadal steroid hormone receptors in modulating stress related responses in an animal model of PTSD (2012) (2)
- Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder (2021) (2)
- Utility of neuroleptic blood levels in the treatment of acute psychosis. (1986) (2)
- Developing cross-national CME for mental disorders in Europe* (2001) (2)
- Obsessive compulsive disorder: Opportunities within and beyond the serotonergic domain (1997) (2)
- Obsessive‐Compulsive Disorder: Diagnostic Considerations and an Epidemiological Update (2001) (2)
- Obsessive-compulsive disorder. (2008) (2)
- Sleep deprivation in rapid-cycling bipolar affective disorder: case report (1992) (2)
- Predictive factors of resistance to antidepressants in bipolar depression: results from a European multicentre study (2006) (2)
- Treatment of obsessive compulsive disorder: Algorithms for pharmacotherapy. (1997) (2)
- Digital psychological first aid for Ukraine. (2022) (2)
- The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs. (2022) (2)
- Abstracts of the 15th Annual Meeting of the Israel Society for Neuroscience Eilat, Israel, December 3–5, 2006 (2006) (1)
- Treating PTSD — SSRI's and beyond (2000) (1)
- The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder (2021) (1)
- High occupational level is associated with poor response to the treatment of depression: A replication study (2019) (1)
- S.21.03 Developing an animal model for post-traumatic stress disorder (2003) (1)
- Hyperlocomotion induced by dopamine or cholecystokinin + dopamine in the nucleus accumbens is not modified by chronic lithium treatment (1989) (1)
- Broadening the treatment indication: Is the term antipsychotic still justified? (2003) (1)
- The impact of catechol-O-methyltransferase (COMT) pharmacogenetics on treatment resistance in major depressive disorder detected by capillary electrophoresis (2008) (1)
- Excitatory Amino Acids and Their Antagonists (2015) (1)
- S-29-3 New insights to the serotonin hypothesis of OCD (1996) (1)
- The Fourth IOCDC (2000) (1)
- Current epidemiological findings and diagnostic issues in PTSD (1998) (1)
- Treatment‐Resistant Mood Disorders: From Diagnosis to Treatment (2005) (1)
- Are All Atypical Antipsychotics Equal for the Treatment of Cognition and Affect in Schizophrenia? (2004) (1)
- Leveraging technology to improve military mental health: Novel uses of smartphone apps (2020) (1)
- Research Domain Criteria (RDoC): A Perspective to Probe the Biological Background behind Treatment Efficacy in Depression. (2021) (1)
- Treatment-algorithms of bipolar disorder (2000) (1)
- Serotonin and Beyond: A Neurotransmitter Perspective of OCD (2012) (1)
- SASOP Biological Psychiatry Congress 2013 Abstracts (2013) (1)
- P.8.b.001 Secondary prevention in depression, bipolar and addiction via mobile phone (2014) (1)
- Acute OCD in veterans with PTSD (2012) (1)
- ***This is a self-archiving copy and does not fully replicate the published version*** Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study (2008) (1)
- Diagnosis and treatment of obsessive-compulsive symptoms in schizophrenia (1992) (1)
- Is there a Role for Antipsychotics in OCD? (2009) (1)
- Sexual Dimorphism in obsessive-compulsive disorder (2004) (1)
- P.4.018 General error monitoring system dysfunction in obsessive compulsive disorder patients: an event-related potential study (2013) (1)
- P.3.013 Genetic variants in ST8SIA2 gene influence treatment outcome in treatment resistant depression: a European multicenter study (2014) (1)
- Brain Pathways of Traumatic Memory: Evidence from an Animal Model of PTSD (2018) (1)
- Poster Session 2: ORGANIC MENTAL DISORDERS AND MEMORY AND COGNITIVE DYSFUNCTIONS (2007) (0)
- Clinical predictors of antidepressant response and remission in treatment resistant depression (2007) (0)
- Corrigendum to “Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.” [Progress in Neuro-Psychopharmacology & Biological Psychiatry 44 (2013) 271–278] (2013) (0)
- P.2.b.035 The combined effect of genetic polymorphisms and clinical parameters on treatment response and resistance in major depressive disorder (2014) (0)
- A Congratulatory Note (2003) (0)
- P.0882 A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response (2021) (0)
- Cyclic AMP and GMP in the cerebrospinal fluid after high-dose haloperidol treatment. (1984) (0)
- P.2.f.011 Socio-demographic and clinical predictors of non response/non remission in treatment resistant depressed patients: a systematic review (2014) (0)
- P.1.a.016 CHL1 gene: a new promising antidepressant response marker in major depression (2013) (0)
- Manifesto for an ECNP Neuromodulation Thematic Working Group (TWG): Non-invasive brain stimulation as a new Super-subspecialty (2021) (0)
- Clinical Decision-Making in Psychiatry (2002) (0)
- Diagnosis of Posttraumatic Stress Disorder Following Surgery for Primary Rhegmatogenous Retinal Detachment (2011) (0)
- Contents Vol. 46, 2013 (2013) (0)
- P.2.f.015 A prospective study of escitalopram in treatment resistant depression not responding to venlafaxine (2013) (0)
- Fluvoxamine in the treatment of severe depression (2004) (0)
- New vistas in OCD (1999) (0)
- SA105A GENOME-WIDE ASSOCIATION STUDY OF TREATMENT-RESISTANT DEPRESSION AND META-ANALYSIS OF THREE INDEPENDENT SAMPLES (2019) (0)
- M74 HIGHER POLYGENIC RISK SCORES FOR SCHIZOPHRENIA MAY BE SUGGESTIVE OF NON-RESPONSE TO DRUGS FOR DEPRESSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (2019) (0)
- 生物学的精神医学会世界連合[WFSBP]不安障害・強迫性障害・PTSDの薬物治療ガイドライン (2005) (0)
- P-13 Cholesterol and suicidality in major depression: a pilot study (1996) (0)
- Exercise Maintains Dendritic Complexity in an Animal Model of PTSD. (2016) (0)
- P.179 Polygenic risk scores for multiple psychiatric, inflammatory and cardio-metabolic traits highlight possible genetic overlap with suicide attempt (2020) (0)
- 58 PREDICTION OF TREATMENT-RESISTANT DEPRESSION USING EXOME SEQUENCE AND GENOME-WIDE DATA (2019) (0)
- Does the Effect of Lithium on G-Proteins Have Behavioral Correlates? (1990) (0)
- P.1.a.012 New insights from cell adhesion molecules in antidepressant action: role of ITGB3 and GAP43 genes (2014) (0)
- S.26.05 Early pharmacological intervention in PTSD: an update (2010) (0)
- Hydrocortisone in the emergency department: a prospective, double-blind, randomized, controlled PTSD study. Hydrocortisone during golden hours. (2022) (0)
- P.4.d.001 General error monitoring system dysfunction in obsessive compulsive disorder patients: an event related potential study (2013) (0)
- Trauma- and Stressor-Related Disorders (2014) (0)
- High dose corticosterone immediately after stress exposure prevents hippocampal cytoarchitecture and neuronal plasticity damage in an animal model of PTSD (2012) (0)
- The Role of Glucocorticoids in the (Mal)adaptive Response to Traumatic Experience (2018) (0)
- Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder. (2023) (0)
- P0212 - Psychiatric bridges- finding a linkage between fibromyalgia and the premenstrual syndrome (2008) (0)
- Methodological issues in PTSD research (1999) (0)
- P.057 A genetic predictor of treatment-resistant depression using exome sequencing and genome-wide genotyping (2019) (0)
- 10 Deep transcranial magnetic stimulation of the anterior cingulate cortex in obsessive compulsive disorder patients (2016) (0)
- The Third IOCDC (1999) (0)
- E.07.01 Pharmacology-based nomenclature – Introducing the concept and the template (2014) (0)
- S.26.01 An innovative animal model of PTSD and its role in translational research (2010) (0)
- SU85 WHOLE EXOME SEQUENCING REVEALS RISK FACTORS IN TREATMENT RESISTANT DEPRESSION (2019) (0)
- SA84 PLEIOTROPIC GENES IN PSYCHIATRY: EFFECTS OF CALCIUM CHANNELS AND THE STRESS-RELATED FKBP5 GENE ON ANTIDEPRESSANT RESPONSE AND TREATMENT RESISTANCE (2019) (0)
- Acute Optic Neuropathy and Development of Posttraumatic Stress Disorder (2017) (0)
- Genetic dissection of the clinical heterogeneity of major depressive disorder (2022) (0)
- W29. METABOLIZING STATUS OF CYP2C19 IN ANTIDEPRESSANT RESPONSE AND SIDE EFFECTS: RESULTS FROM A NATURALISTIC STUDY (2021) (0)
- Psychiatric bridges- finding a linkage between fibromyalgia and the premenstrual syndrome (0)
- Psychotherapy employed additionally to Psychopharmacotherapy is not related to Better Treatment Outcome in Major Depressive Disorder (2022) (0)
- Subject Index Vol. 7, 1981 (1981) (0)
- [Salivary enzyme activity in disorders of the parotid gland]. (1975) (0)
- The Cape Town consensus statement regarding the diagnosis and treatment of obsessive-compulsive disorder (2007) (0)
- P.2.b.068 Epidemiology of psychopharmacological options in unipolar major depression in European tertiary psychiatric treatment centers (2016) (0)
- Escitalopram in the treatment of obsessive-compulsive (2008) (0)
- P.2.b.013 Socio-demographic and clinical predictors of antidepressant remission and response in treatment resistant depression (2014) (0)
- Clinical predictors of treatment resistant depression: Replication results from the European multicenter study (2018) (0)
- [Clinical correlates of neuroleptic blood levels]. (1984) (0)
- SEROTONIN RECEPTOR SUBSETS IN OBSESSIVE-COMPULSIVE DISORDER (1994) (0)
- Comparison of clomipramine and desipramine treatments in panic disorder (1989) (0)
- S.21.05 Ten myths of PTSD (2003) (0)
- S.2.01 Can PTSD be prevented? Strategic interventions in the ‘golden hours’ (2009) (0)
- Researching Schizophrenia: The Difficulty of Subtyping (2002) (0)
- P.3.026 Clinical and genetic predictors of antidepressant response and remission in treatment-resistant depression (2012) (0)
- Obsessive‐Compulsive Disorder: Biology and Treatment, a Generation of Progress (2001) (0)
- Atypical Antipsychotics in Treating Anxiety disorders – Focus on OCD Obsessive Compulsive disorder (0)
- P.1.014 PPP3CC: a new candidate gene in antidepressant response (2014) (0)
- Introduction (2009) (0)
- P.2.b.026 Social adjustment among therapy responder patients with mood disorders (2013) (0)
- PS75. Psychopharmacoepidemiology of Major Depressive Disorder in European Tertiary Psychiatric Treatment Centers (2016) (0)
- P.3.003 Pleiotropic genes in psychiatry: calcium channels and the stress-related FKBP5 gene in antidepressant resistance (2018) (0)
- Editorial (2000) (0)
- P.3.038 The effect of neuroleptic drugs on olfactory sensitivity in schizophrenia (1996) (0)
- Pharmacogenetics of CYP2C19 in response and side effects to major depression treatment: a machine learning approach (2022) (0)
- P.2.f.006 Temperament and character inventory and response to antidepressant treatment (2015) (0)
- Saliva metabolome alterations after acute stress (2022) (0)
- Melancholic features and typical neurovegetative symptoms of major depressive disorder show specific polygenic patterns. (2022) (0)
- SO 01. Diffi culties in treating resistant depression SO 0101. TRD - The concept, the staging and the predictors (2009) (0)
- P.3.02 Personality traits as predictors of treatment response in patient with affective disorder (2004) (0)
- Broadening our horizon: response to commentaries. (2012) (0)
- P.3.015 Socio-demographic and clinical predictors of antidepressant remission and response in treatment resistant depression (2014) (0)
- Ten-Year Follow-Up of Earthquake Survivors: Long-Term Study on the Course of PTSD Following a Natural Disaster. (2023) (0)
- Treatment of posttraumatic stress disorder — an update (2001) (0)
- Mood stabilizers as an Achilles’ heel for indication‐based nomenclature and roles of Neuroscience‐based Nomenclature (2018) (0)
- A sustainable approach to depression: Moving from words to actions (2018) (0)
- E.01.01 Pharmacological treatment of resistant OCD (2019) (0)
- S-75-2 Contemplating neurosurgery for refractory OCD. Theperspective of the referring psychiatrist (1996) (0)
- OCD: From neurasthenia to neuroscience (1998) (0)
- P.335 Drug repositioning for treatment-resistant depression by comparing genetic predictors with known drug targets (2020) (0)
- Ten possible explanations for resistant depression (2007) (0)
- Front & Back Matter (2013) (0)
- Stress and Animal Models of Posttraumatic Stress Disorder (2011) (0)
- Polygenic risk scores for psychiatric, inflammatory, and cardio-metabolic traits and diseases highlight possible genetic overlaps with suicide attempt and treatment-emergent suicidal ideation European College of Neuropsychopharmacology (ECNP) Network on Suicide Research and Prevention, (2021) (0)
- Drug repositioning for treatment-resistant depression: insights from a pharmacogenomic study (2020) (0)
- Myths and Facts about Post Traumatic Stress Disorder (2004) (0)
- P.2.f.014 PPP3CC gene in antidepressant response: results from three independent samples (2013) (0)
- Contents, Vol. 2, 1976 (1976) (0)
- S.03.04 5HT1D hypothesis of OCD — an update (2004) (0)
- Preventive Maintenance for Athletes. (1975) (0)
- 174. The effect of neuroleptic drugs on olfactory sensitivity in schizophrenia (1996) (0)
- Interventions Following Terrorism From 3 Months to 5 Years Post-Event: (517302011-069) (2013) (0)
- Promoter methylation of the glucocorticoid receptor following trauma may be associated with subsequent development of PTSD. (2023) (0)
- P.141 Topological data analysis for genetic-driven stratification of patients with major depressive disorder (2020) (0)
- Brain-derived neurotrophic factor (BDNF) gene polymorphisms: Influence on treatment response phenotypes of major depressive disorder (2010) (0)
- Emergent Clinical Issues in Problem Gambling (2010) (0)
- Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study. (2021) (0)
- Editorial (2000) (0)
- P.3.066 PTSD - early intervention with sertraline: Preliminary data from prospective study (2003) (0)
- Speaker 2: Trevor Robbins, UK (2016) (0)
- F105AN EXOME SEQUENCING STUDY IN TREATMENT-RESISTANT DEPRESSION (2019) (0)
- CHILDHOOD, ADOLESCENT AND ADULT AGE AT ONSET AND RELATED CLINICAL CORRELATES IN OBSESSIVE-COMPULSIVE DISORDER: A REPORT FROM THE INTERNATIONAL COLLEGE OF OBSESSIVE-COMPULSIVE DISORDERS (ICOCS) (2017) (0)
- Diagnostic Accuracy of the Posttraumatic Stress Disorder Checklist-civilian Version in a Predictors of Dropout in an Outpatient Treatment for Problem Drinkers including Cognitive-behavioral Therapy and the Opioid Antagonist Naltrexone. the Relationship between Borderline Personality Disorder and B (0)
- Genetic variants within neuronal cell adhesion genes and antidepressant response in three independent groups (2015) (0)
- Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial. (2022) (0)
- Subject Index Vol. 2, 1976 (1976) (0)
- P.021 Social dysfunction in mood disorders and schizophrenia: clinical correlates in four independent samples (2019) (0)
- 121 COMPULSIVE AND IMPULSIVE ASPECTS OF SELF-INJURIOUS BEHAVIOR (2002) (0)
- Conclusion and Future Directions (2012) (0)
- S03.04 Is OCD a form of addiction? (2000) (0)
- P-710 - the Impact of Bdnf Gene Polymorphisms on Suicidality in Treatment Resistant Major Depressive Disorder - a European Multicenter Study (2012) (0)
- [Caffeine--the most commonly used psychoactive drug, worldwide]. (1994) (0)
- Traumatic Stress and Posttraumatic Stress Disorder, the Israeli Experience (2007) (0)
- Erratum: Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care (International Journal of Psychiatry in Clinical Practice (2012) 16 (77-84)) (2012) (0)
- The potential beneficial effect of sleep deprivation following traumatic events to preventing PTSD: Review of current insight regarding sleep, memory, and trauma resonating with ancient rituals—Àìsùn Oku (African) and Tsuya (Japanese) (2023) (0)
- A genome-wide association study of treatment-resistant depression and meta-analysis with STAR*D (2018) (0)
- S.01.02 Treating schizophrenic patients with OCD and anxiety (2006) (0)
- PHARMACOGENETICS OF CYP2C19 IN RESPONSE AND SIDE EFFECTS TO MAJOR DEPRESSIVE DISORDER TREATMENT: A MACHINE LEARNING APPROACH (2022) (0)
- Secondary prevention of chronic PTSD by early and short administration of esitalopram : a prospective randomized controlled double blind trial (2017) (0)
- P.2.f.024 High occupational level is associated with poor response to treatment of depression (2016) (0)
- Neurobiology of resistant depression (1998) (0)
- Age as a moderating factor of treatment resistance in depression. (2023) (0)
- S.02.05 European research programme on treatment resistant depression (2007) (0)
- Brain imaging as a tool to predict treatment response (1998) (0)
- Factors associated to resistant depression (2007) (0)
- P.2.b.026 The relation between major depressive disorder and comorbid generalized anxiety disorder – results from a European multicenter, cross-sectional survey (2017) (0)
- Attrition in treatment-resistant depression: predictors and clinical impact. (2019) (0)
- Foreword (1996) (0)
- Serotonin in Major Psychiatric (1991) (0)
- Polygenic risk scores for psychiatric, inflammatory, and cardio-metabolic traits and diseases highlight possible genetic overlaps with suicide attempt and treatment-emergent suicidal ideation (2021) (0)
- Anxiety (2002) (0)
- PS87. An update on prediction of treatment outcome in treatment resistant depression (2016) (0)
- Recommendations for the Long-Term Treatment of Anxiety Disorders (2003) (0)
- P.4.d.009 From over-awareness to obsessive behaviour – error monitoring system dysfunction in patients with obsessive–compulsive disorder (2014) (0)
- S.2.4 Underlying pathology and treatment of social phobia (2005) (0)
- Characterization of medication side effects in patients with mostly resistant depression in a real-world setting. (2022) (0)
- Timing and the Rhythm of the Mind (2001) (0)
- Comparison of serotonergic versus non-serotonergic medication in obsessive-compulsive disorder and panic disorder (1993) (0)
- A neuroscience-based nomenclature for psychotropic drugs (2020) (0)
- O-16-8 The effect of neuroleptic drugs on olfactory sensitivity in schizophrenia (1996) (0)
- Clinical and genetic predictors of antidepressant response and remission in treatment-resistant depression (2012) (0)
- [The serotonin syndrome]. (1997) (0)
- KL.02 New biological and diagnostic concepts in OCD (2007) (0)
- Translationally relevant modeling of PTSD in rodents (2013) (0)
- Extending Neuropsychological Testing (2002) (0)
- P.3.04 Sumatriptan effect on regional brainperfusion: predicting therapeutic response in OCD (2005) (0)
- P.321 Clinical parameters associated with augmentation and combination treatment in unipolar depression (2019) (0)
- A learning in OCD/ schizophrenia patients (2003) (0)
- Erratum to: Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder (2013) (0)
- Speaker 1: Dan Stein, South Africa (2016) (0)
- Prescribing patterns of psychiatric drugs in major depressive disorder – Findings from a large European multicenter, cross-sectional study (2017) (0)
- Contents, Vol. 7, 1981 (1981) (0)
- Speaker 4: Joseph Zohar, Israel (2016) (0)
- EXPLORING SOCIODEMOGRAPHIC AND CLINICAL CORRELATES OF OLDER ADULTS WITH OBSESSIVE-COMPULSIVE DISORDER: A REPORT FROM THE INTERNATIONAL COLLEGE OF OBSESSIVE-COMPULSIVE DISORDERS (ICOCS) (2018) (0)
- P.171 Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Joseph Zohar?
Joseph Zohar is affiliated with the following schools:
